Discounted Cash Flow Rating

Strong Sell

Return on Equity Rating

Strong Sell

Debt to Equity Rating

Strong Sell

Price to Earnings Rating

Strong Sell

Analyst Rating

Strong Sell

Upgrade To View Simple Moving Average Rating

Upgrade

Upgrade To Get Access

Upgrade To View Exponential Moving Average Rating

Upgrade

Upgrade To Get Access

Upgrade To View Relative Strength Index Rating

Upgrade

Upgrade To Get Access

Upgrade To View Standard Deviation Rating

Upgrade

Upgrade To Get Access

Upgrade To View Williams %R Rating

Upgrade

Upgrade To Get Access

Upgrade To View Average Directional Index Rating

Upgrade

Upgrade To Get Access

Upgrade To View Insider Trading Rating

Upgrade

Upgrade To Get Access

Wall Street Data Solutions Rating

Neutral

B

Cel-Sci Corporation (CVM)

Biological Products, (no Disgnostic Substances)

https://www.cel-sci.com

CEL-SCI Corp is a player in the biotechnology sector. It is engaged in the research and development at developing the treatment of cancer and other diseases by using the immune system. The company is focused on activating the immune system to fight cancer and infectious diseases. It is focused on the development of Multikine (Leukocyte Interleukin, Injection), investigational immunotherapy under development for the treatment of certain head and neck cancers, and anal warts or cervical dysplasia.

8229 BOONE BLVD ., SUITE 802
VIENNA, VA

Current Price

---.--

% Change Today

0.00%

Change Amt. Today

0.00

Active Status

Active

Listing Date

10/10/1991

Market Cap

66,100,848

Shares Outstanding

49,980,000

Weighted SO

49,980,804

Total Employees

N/A

Upcoming Earnings

08/09/2024

Similar Tickers

CTIC --.--%

AGEN --.--%

CTIC --.--%

AEZS --.--%

CYCC --.--%

BCRX --.--%

Beta

0.6670

Last Div

0.0000

Range

1.02-3.23

Chg

-0.0050

Avg Vol

1314861

Mkt Cap

66100848

Exch

AMEX

Country

US

Phone

703 506 9460

DCF Diff

1.3519

DCF

-0.2119

Div Yield

0.0000

P/S

0.0000

EV Multiple

-3.2804

P/FV

7.2646

Div Yield %

0.0000

P/E

-2.1642

PEG

-0.1133

Payout

0.0000

Current Ratio

0.6433

Quick Ratio

0.1793

Cash Ratio

0.0699

DSO

0.0000

DIO

234.6178

Op Cycle

0.0000

DPO

125.7393

CCC

0.0000

Gross Margin

0.0000

Op Margin

0.0000

Pretax Margin

0.0000

Net Margin

0.0000

Eff Tax Rate

-0.0131

ROA

-1.1817

ROE

-2.3388

ROCE

-1.4923

NI/EBT

1.0000

EBT/EBIT

1.0268

EBIT/Rev

0.0000

Debt Ratio

0.5041

D/E

1.4319

LT Debt/Cap

0.5404

Total Debt/Cap

0.5888

Int Coverage

-49.2620

CF/Debt

-1.5664

Equity Multi

2.8406

Rec Turnover

0.0000

Pay Turnover

2.9028

Inv Turnover

1.5557

FA Turnover

0.0000

Asset Turnover

0.0000

OCF/Share

-0.3520

FCF/Share

-0.3538

Cash/Share

0.0071

OCF/Sales

0.0000

FCF/OCF

1.0052

CF Coverage

-1.5664

ST Coverage

-8.7647

CapEx Coverage

-192.5399

Div&CapEx Cov

-192.5399

P/BV

7.2646

P/B

7.2646

P/S

0.0000

P/E

-2.1642

P/FCF

-3.4602

P/OCF

-3.2389

P/CF

-3.2389

PEG

-0.1133

P/S

0.0000

EV Multiple

-3.2804

P/FV

7.2646

DPS

0.0000

Latest Headlines (EST)

No Headlines Found

Revenue Product Segmentation

Dividend History

Cash Value Ex-Dividend Date Declaration Date Record Date Pay Date
0.25 08/28/1996 11/30/-0001 11/30/-0001 11/30/-0001